Price | 1W % | 1M % | 3M % | 6M % | 1Y % | YTD % |
|---|---|---|---|---|---|---|
-- | -- | -- | -- | -- | -- | -- |
AI Generated Qualitative Analysis
Your time is precious, so save it. Use AI to get the most important information from the business.
Learn about GlobeStar Therapeutics Corporation
GlobeStar Therapeutics Corporation News
Mar 28, 2024 - accesswire.com
Globestar Therapeutics Update on Project Amethyst(TM) and Recent Financials
Nov 2, 2023 - accesswire.com
GlobeStar Therapeutics Enters Into Definitive Agreement With Advanced Innovative Partners To Develop Clinical Studies and Strategies for Multiple Sclerosis Treatment
Sep 28, 2023 - accesswire.com
Globestar Therapeutics Enters into Definitive Agreement with SMI Healthcare to Manage Clinical Trial, Regulatory Filings, Manufacturing and Sales in MEA Region for Multiple Sclerosis Treatment
Oct 11, 2021 - accesswire.com
GlobeStar Therapeutics Corporation Has Been Upgraded to the QB Tier on OTC Markets
GlobeStar Therapeutics Corporation Quantitative Score
About GlobeStar Therapeutics Corporation
GlobeStar Therapeutics Corporation, a clinical stage pharmaceutical company, focuses on developing a patented formulation of drugs for the treatment of multiple sclerosis and other neurodegenerative diseases. The company was formerly known as AngioSoma, Inc. and changed its name to GlobeStar Therapeutics Corporation in July 2021. The company was incorporated in 2016 and is based in Richland, Washington.
GlobeStar Therapeutics Corporation Earnings & Revenue
What’s This Company Really Worth? Find Out Instantly.
Warren Buffett’s go-to valuation method is Discounted Cash Flow (DCF). Our tool makes it effortless — no spreadsheets, just answers in a few clicks.
GlobeStar Therapeutics Corporation Financials
Table Compare
Compare GSTC metrics with: | |||
|---|---|---|---|
Earnings & Growth | GSTC | None | |
EPS (TTM) YoY Growth | -- | -- | |
Revenue (TTM) YoY Growth | -- | -- | |
Valuation (TTM) | GSTC | None | |
Price/Earnings Ratio | -- | -- | |
Price/Sales Ratio | -- | -- | |
Profitability & Efficiency (TTM) | GSTC | None | |
Net Profit Margin | -- | -- | |
Return on Equity | -- | -- | |
Financial Health (TTM) | GSTC | None | |
Debt/Assets Ratio | -- | -- | |
Assets/Liabilities Ratio | -- | -- | |
GlobeStar Therapeutics Corporation Income
GlobeStar Therapeutics Corporation Balance Sheet
GlobeStar Therapeutics Corporation Cash Flow
GlobeStar Therapeutics Corporation Financials Over Time
Analysts Rating
Strong Buy
Buy
Hold
Sell
Strong Sell
Metrics Scores
| Metrics | Score |
|---|---|
| Discounted Cash Flows | Strong Sell |
| Return on Equity | Strong Buy |
| Return on Assets | Strong Sell |
| Debt/Equity Ratio | Strong Sell |
| Price/Earnings Ratio | Strong Sell |
| Price/Book Ratio | Strong Sell |
Price Targets
Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.
Historical Market Cap
Shares Outstanding
GlobeStar Therapeutics Corporation Executives
| Name | Role |
|---|---|
| Mr. James C. Katzaroff | President, Chief Executive Officer, Secretary, Principal Executive Officer & Chairman of the Board |
| Mr. David Croom | Executive Vice President |
| Ms. Brooke Greenwald | Chief Marketing Officer |
| Name | Role | Gender | Date of Birth | Pay |
|---|---|---|---|---|
| Mr. James C. Katzaroff | President, Chief Executive Officer, Secretary, Principal Executive Officer & Chairman of the Board | Male | 1957 | 180K |
| Mr. David Croom | Executive Vice President | Male | -- | |
| Ms. Brooke Greenwald | Chief Marketing Officer | Female | -- |
GlobeStar Therapeutics Corporation Insider Trades
| Date | 23 Nov |
| Name | Chicoski Robert |
| Role | CFO/TREASURER |
| Transaction | Disposed |
| Type | |
| Shares | 0 |
| Date | 10 Feb |
| Name | Chicoski Robert |
| Role | CFO |
| Transaction | Disposed |
| Type | |
| Shares | 0 |
| Date | 3 Apr |
| Name | KATZAROFF JAMES C |
| Role | CEO |
| Transaction | Acquired |
| Type | J-Other |
| Shares | 7042253 |
| Date | 12 May |
| Name | KATZAROFF JAMES C |
| Role | CEO |
| Transaction | Acquired |
| Type | A-Award |
| Shares | 30000000 |
| Date | 24 Feb |
| Name | KATZAROFF JAMES C |
| Role | CEO |
| Transaction | Acquired |
| Type | A-Award |
| Shares | 35000000 |
| Date | Name | Role | Transaction | Type | Shares |
|---|---|---|---|---|---|
| 23 Nov | Chicoski Robert | CFO/TREASURER | Disposed | 0 | |
| 10 Feb | Chicoski Robert | CFO | Disposed | 0 | |
| 3 Apr | KATZAROFF JAMES C | CEO | Acquired | J-Other | 7042253 |
| 12 May | KATZAROFF JAMES C | CEO | Acquired | A-Award | 30000000 |
| 24 Feb | KATZAROFF JAMES C | CEO | Acquired | A-Award | 35000000 |